Back

Changes in anticoagulation treatment and associated resolution or persistence of left atrial thrombus. Insights from LATTEE registry

31 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Anticoagulation in atrial fibrillation: striking the balance Oral Anticoagulation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Monika Gawalko

Medical University of Warsaw, Warsaw (Poland)

3 More presentations in this session

Presentation thumbnail
Standard modifiable cardiovascular risk factors and prognostic outcomes in non-valvular atrial fibrillation on oral anticoagulants
Doctor H. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Competing risks of ischemic stroke, intracranial bleeding, and mortality in patients with atrial fibrillation and prior intracranial hemorrhage without an anticoagulation regimen
Doctor P. Tiili (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Efficacy of anticoagulation in atrial fibrillation: evidence from 36 years of randomized controlled trials - a meta-analysis
Mr P. Sumariva (Rio Do Sul, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Anticoagulation in atrial fibrillation: striking the balance

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative effectiveness of different management strategies for left atrial appendage thrombus in patients on optimal NOAC therapy
thumbnail
Congress Presentation
Therapeutic strategies and long-term follow-up in patients presenting with left atrial thrombus despite oral anticoagulation
thumbnail
Congress Presentation
Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources